903 related articles for article (PubMed ID: 28732842)
21. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
23. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review.
Zhang S; King D; Rosen VM; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():417-438. PubMed ID: 32161454
[TBL] [Abstract][Full Text] [Related]
24. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
25. COPD: misuse of inhaler devices in clinical practice.
Duarte-de-Araújo A; Teixeira P; Hespanhol V; Correia-de-Sousa J
Int J Chron Obstruct Pulmon Dis; 2019; 14():1209-1217. PubMed ID: 31213798
[No Abstract] [Full Text] [Related]
26. [The importance of selecting the right type of inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD)].
Larsson K; Bjermer L; Svartengren M
Lakartidningen; 2019 Feb; 116():. PubMed ID: 30720857
[TBL] [Abstract][Full Text] [Related]
27. [Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease].
Trushenko NV; Stoliarevich AA; Andriukov BG; Nuralieva GS; Tsareva NA; Lavginova BB; Avdeev SN
Ter Arkh; 2023 Apr; 95(3):210-216. PubMed ID: 37167141
[TBL] [Abstract][Full Text] [Related]
28. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
Grant AC; Walker R; Hamilton M; Garrill K
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
[TBL] [Abstract][Full Text] [Related]
29. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD.
Press VG; Arora VM; Shah LM; Lewis SL; Ivy K; Charbeneau J; Badlani S; Nareckas E; Mazurek A; Krishnan JA
J Gen Intern Med; 2011 Jun; 26(6):635-42. PubMed ID: 21249463
[TBL] [Abstract][Full Text] [Related]
30. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD
Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268
[TBL] [Abstract][Full Text] [Related]
31. [The choice of inhalation device: A medical act].
Devillier P; Salvator H; Roche N
Rev Mal Respir; 2015 Jun; 32(6):599-607. PubMed ID: 25433462
[TBL] [Abstract][Full Text] [Related]
32. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
[TBL] [Abstract][Full Text] [Related]
33. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
[TBL] [Abstract][Full Text] [Related]
35. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
[TBL] [Abstract][Full Text] [Related]
36. Aerosol Delivery Devices for Obstructive Lung Diseases.
Pleasants RA; Hess DR
Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
[TBL] [Abstract][Full Text] [Related]
37. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults.
Melani AS; Zanchetta D; Barbato N; Sestini P; Cinti C; Canessa PA; Aiolfi S; Neri M;
Ann Allergy Asthma Immunol; 2004 Nov; 93(5):439-46. PubMed ID: 15562882
[TBL] [Abstract][Full Text] [Related]
38. What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape.
Lavorini F; Janson C; Braido F; Stratelis G; Løkke A
Ther Adv Respir Dis; 2019; 13():1753466619884532. PubMed ID: 31805823
[TBL] [Abstract][Full Text] [Related]
39. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.
Lavorini F; Magnan A; Dubus JC; Voshaar T; Corbetta L; Broeders M; Dekhuijzen R; Sanchis J; Viejo JL; Barnes P; Corrigan C; Levy M; Crompton GK
Respir Med; 2008 Apr; 102(4):593-604. PubMed ID: 18083019
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Poor Inhaler Technique in Older Patients with Asthma or COPD: A Predictive Tool for Clinical Risk and Inhaler Performance.
Maricoto T; Santos D; Carvalho C; Teles I; Correia-de-Sousa J; Taborda-Barata L
Drugs Aging; 2020 Aug; 37(8):605-616. PubMed ID: 32602039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
